SurModics (SRDX) Misses Q2 EPS by 2c; Narrows Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. USO
2. MRVL
3. SPY
4. NVDA
5. BBIO
6. GOOGL
7. OPCH
8. AMD
9. CHRW
10. SKYD

Go back to SurModics (SRDX) Misses Q2 EPS by 2c; Narrows Outlook

Surmodics Reports Second Quarter Fiscal 2017 Results, Updates Fiscal 2017 Financial Guidance

April 27, 2017 7:30 AM EDT

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2017 second quarter, ended March 31, 2017.

Second Quarter Fiscal 2017 Financial Highlights

Total Revenue of $17.5 Million, up 5% year over year; Medical Device revenue increases 10% EPS of $0.04, Non-GAAP EPS of $0.05 Narrows financial outlook for fiscal 2017

"This was an excellent quarter, both in terms of our revenue performance... More